BUY Vijaya Diagnostic Centre Limited — Raja Venkatraman
byRaja VenkatramanHorizon: 1–3 months24 Sept 2026via LiveMint Buy-or-Sell (topic)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
MACD above its signal line — bullish momentum
Technicals · macd·24 Sept · today
Market Trading Guide: Vijaya Diagnostic among 3 stock recommendations for Thursday
NewsEt-Markets·23 Sept · today
Vijaya Diagnostic Centre Ltd has executed a Business Transfer Agreement (BTA) to acquire 100% of Arya Wellness Centre in Guwahati, Assam, for approximately INR 46 Cr. This acquisition marks the compan
BSE · Company Update·11 Sept · 2w ago
Vijaya Diagnostic Centre Limited's Board approved the acquisition of Arya Wellness Centre's diagnostic business in Guwahati for ₹46.20 Crores on a slump sale basis. This acquisition aims to expand the
NSE · Outcome of Board Meeting·11 Sept · 2w ago
Vijaya Diagnostic Centre Ltd approved the execution of a Business Transfer Agreement for 100% acquisition of an integrated diagnostic business.
BSE · Others·11 Sept · 2w ago
Vijaya Diagnostic Centre appoints Dr. Venkata Naresh Yallapragada as CIO
NewsGoogle News·2 Sept · 3w ago
Vijaya Diagnostic Centre: Appoints New Chief Information Officer
NewsGoogle News·2 Sept · 3w ago
Vijaya Diagnostic Centre Limited Announces Appointment of Dr. Venkata Naresh Yallapragada as Chief Information Officer, Effective September 02, 2026
NewsGoogle News·2 Sept · 3w ago
Vijaya Diagnostic Centre files FY26 BRSR report with exchanges
NewsGoogle News·26 Aug · 4w ago
Vijaya Diagnostic Centre: AGM and Dividend Record Dates Announced
NewsGoogle News·26 Aug · 4w ago
Vijaya Diagnostic Centre: Company Secretary Resigns
NewsGoogle News·26 Aug · 4w ago
1 advisor has an active long-term SELL call on this stock
Advisor consensus · adjacent horizon·5 Nov · 11mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

